FireCyte Therapeutics
Cambridge, US · Founded 2021 · Delaware corporation
Founders & leadership
ME
Meredith E FisherDirector
RE
Ruoxi E HuDirector
WE
William E YelleExecutive Officer, Director
CE
Charles E KunschDirector
Reported raises · per SEC filings
Form D private placements▶$5.5MraisedFeb 2022 · 3 investors · OtherRule 506(b)
Officers, directors & promoters on the filing
- Meredith E FisherDirector
- Ruoxi E HuDirector
- William E YelleExecutive Officer, Director
- Charles E KunschDirector
- Offering amount
- $12M
- Amount sold
- $5.5M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.